Understand the benefits and challenges of conducting studies in Latin America in addition to some recent changes that could expedite regulatory timelines.
How global site networks can effectively address timeline, budget and data quality concerns, by providing access to multiple experienced sites within a single network, providing cost savings through reduction of the total number of sites used and recruitment of a large volume of patients.
Change the perception of clinical trials by making them less burdensome for patients overall.
Overview of a recent study conducted to try to determine why there is so much variation and why there are so many inefficiencies and delays in study startup.
What is the medical monitor's role in the latest ICH E6 (r2) guidance and how to get them to adopt technology that will help them experience tangible efficiency and quality gains.
Help sponsors design a more holistic strategy to their managing the clinical supply returns process.
Patient, industry, and regulatory stakeholders shared their perspectives on today's meaning of effective engagement and what the future state of patient engagement will look like. Panelists discussed what they believe should be the outcomes of their investments of effort and how we can engage patients to identify the outcomes that matter most.
In this DIAmond session, prominent thinkers on scientific evidence for support of biomedical decision-making will discuss our readiness to tap Real World Evidence (RWE) for safety and efficacy questions and consider its uses for regulatory purposes. The benefits and challenges of using RWE to generate evidence of sufficient quality for decision-making, following the concept of using fit-for-purpose research tools, were examined.
Clinical packaging, logistics and import/export considerations that should be taken into account when developing a clinical supply strategy in China, Singapore and Japan.
Don't let the complex logistics involved in the handling of clinical supplies in certain regions of the world put your patients at risk or jeopardize both the study budget and timeline.
See how this service can benefit you with shorter lead time, less waste, less stock out risk and no booklet labels.
In this webinar, INC Research/inVentiv Health experts discuss the factors that sponsors must take into account as they design and execute clinical trials in this space, beginning with a review of the immunotherapy landscape.
Transform data into persuasive evidence to document the clinical, economic, and humanistic value of innovative drugs and devices before and after product approval and launch. Ready to learn how?
Medical and regulatory documentation developed by experienced medical writing teams plays a pivotal role in the success of a clinical research project.
Flex Advantage offers enhanced randomization, clinical supply management capabilities and enables the execution of adaptive clinical trials.